Human-supervised Agentic AI for Hypothesis Generation and Experimental Assistance in Drug Repurposing
The study developed RepurAgent, a hierarchical multi-agent AI system in which a supervisor agent and a planning agent coordinate four specialized sub-agents (research, prediction, data, and report) through a human-in-the-loop design with episodic memory and retrieval-augmented generation, and validated it across three scenarios spanning the drug repurposing lifecycle: in Acute Myeloid Leukemia a blinded expert evaluation indicated substantially more novel and mechanistically credible candidates than a vanilla LLM baseline; in a retrospective COVID-19 antiviral screen it prioritized compounds with AUC-ROC up to 0.